Emergent BioSolutions (EBS) Share-based Compensation (2010 - 2026)
Emergent BioSolutions (EBS) posted Share-based Compensation of $6.0 million for Q2 2026, up 114.29% on a QoQ basis from $2.8 million in Q1 2026, and up 30.43% year-over-year from $4.6 million in Q2 2025.
Powered by 
Analysis
Emergent BioSolutions (EBS) Share-based Compensation (2010 - 2026) Analysis & Trends
Emergent BioSolutions has reported Share-based Compensation for 17 years, with the latest figure at $6.0 million in Q2 2026.
- On a quarterly basis, Share-based Compensation rose 30.43% year-over-year to $6.0 million in Q2 2026; TTM through Jun 2026 was $18.9 million, a 48.82% increase from a year earlier, with the FY2025 full-year figure at $16.2 million, down 10.0% from the prior year.
- Share-based Compensation was $6.0 million for Q2 2026 at Emergent BioSolutions, up from $2.8 million in the prior quarter.
- The five-year high for Share-based Compensation was $12.3 million in Q2 2022, with the low at $1.5 million in Q1 2025.
- Average Share-based Compensation over 5 years is $6.2 million, with a median of $5.4 million recorded in 2024.
- The largest YoY upside for Share-based Compensation was 108.7% in 2025 against a maximum downside of 74.58% in 2025.
- Over 5 years, Share-based Compensation stood at $11.7 million in 2022, then plunged by 65.81% to $4.0 million in 2023, then rose by 7.5% to $4.3 million in 2024, then increased by 23.26% to $5.3 million in 2025, then climbed by 13.21% to $6.0 million in 2026.
- The last three Share-based Compensation figures came in at $6.0 million (Q2 2026), $2.8 million (Q1 2026), and $5.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.47 Bn | 628.71 Bn | 17.26 Bn | -950.00 Mn |
| 2 | AbbVie | 467.46 Bn | 460.93 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 369.31 Bn | 362.22 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 269.03 Bn | 261.74 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.11 Bn | 146.71 Bn | 10.94 Bn | 249.00 Mn |
| 6 | Bristol Myers Squibb | 127.96 Bn | 116.89 Bn | 9.25 Bn | 135.00 Mn |
| 7 | Sanofi | 51.83 Bn | 44.86 Bn | 10.79 Bn | - |
| 8 | BeOne Medicines | 41.33 Bn | 36.23 Bn | 1.53 Bn | 137.41 Mn |
| 9 | Revolution Medicines | 41.30 Bn | 41.30 Bn | - | 277.20 Mn |
| 10 | Emergent BioSolutions | 335.50 Mn | 194.60 Mn | 137.20 Mn | 6.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.00 Mn |
| Mar 31, 2026 | 2.80 Mn |
| Dec 31, 2025 | 5.30 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 4.60 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Jun 30, 2024 | 5.50 Mn |
| Mar 31, 2024 | 5.90 Mn |
| Dec 31, 2023 | 4.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 8.30 Mn |
| Mar 31, 2023 | 6.80 Mn |
| Dec 31, 2022 | 11.70 Mn |
| Sep 30, 2022 | 11.20 Mn |
| Jun 30, 2022 | 12.30 Mn |
| Mar 31, 2022 | 9.90 Mn |
| Dec 31, 2021 | 10.10 Mn |
| Sep 30, 2021 | 10.40 Mn |
API Access
Emergent BioSolutions Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();